CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result.
Author
Carolyn Wasserheit-Lieblich
Chau T. Dang
+14Â more
Clifford A. Hudis
Daniel Fontes Santos De Teive E Argolo
Elizabeth Anne Comen
Jose Baselga
Larry Norton
Lillian Mary Smyth
Nancy T. Sklarin
Neil M. Iyengar
Pamela Drullinsky
Sarat Chandarlapaty
Steven Sugarman
Sujata Patil
Tiffany A. Traina
Tiffany A. Troso-Sandoval
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Dose Dense Cyclophosphamide, Methotrexate, Fluorouracil is Feasible at 14-Day Intervals: A Pilot Study of Every-14-Day Dosing as Adjuvant Therapy for Breast Cancer
Author
Andrew D. Seidman
Bear
+45Â more
Bonadonna
Bonnadonna
Bonnadonna
Bonnadonna
Carolyn Wasserheit-Lieblich
Cheang
Citron
Clifford Hudis
Coiffier
Colleoni
Colleoni
Deena Atieh-Graham
Diana Lake
Fornier
Fornier
Gabriella D'Andrea
Gianni
Gilewski
Halaas
Hamangi Patel
Hudis
Hudis
Jeffrey Yuan
Kolb
Larry Norton
Lindeman
McArthur
Monica N. Fornier
Nancy Mills
Nancy Sklarin
Norton
Pamela Drullinsky
Rueda
Singletary
Skipper
Steven M. Sugarman
Sugarman
Sujata Patil
Tancini
Tannock
Teresa Gilewski
Tiffany Traina
Tiffany Troso-Sandoval
Womer
Wood
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref